260 related articles for article (PubMed ID: 34758305)
1. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability.
Shimizu K; Gi M; Suzuki S; North BJ; Watahiki A; Fukumoto S; Asara JM; Tokunaga F; Wei W; Inuzuka H
Cell Rep; 2021 Nov; 37(6):109988. PubMed ID: 34758305
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme USP20 regulates the stability of the MCL1 protein.
Feng J; Liu P; Li X; Zhang D; Lin H; Hou Z; Guo C; Niu Y; Dai B; Wang O; Qi M; Wang H; Zhou H
Biochem Biophys Res Commun; 2022 Feb; 593():122-128. PubMed ID: 35063767
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
[TBL] [Abstract][Full Text] [Related]
5. DDX3 interacts with USP9X and participates in deubiquitination of the anti-apoptotic protein MCL1.
Lai MC; Chen YP; Li DA; Yu JS; Hung HY; Tarn WY
FEBS J; 2022 Feb; 289(4):1043-1061. PubMed ID: 34606682
[TBL] [Abstract][Full Text] [Related]
6. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options.
Wu X; Luo Q; Liu Z
Cell Death Dis; 2020 Jul; 11(7):556. PubMed ID: 32699213
[TBL] [Abstract][Full Text] [Related]
8. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation.
Lv C; Zhao G; Sun X; Wang P; Xie N; Luo J; Tong T
Oncotarget; 2016 Sep; 7(37):60366-60382. PubMed ID: 27542221
[TBL] [Abstract][Full Text] [Related]
10. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
11. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
13. TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression.
Zhang X; Li CF; Zhang L; Wu CY; Han L; Jin G; Rezaeian AH; Han F; Liu C; Xu C; Xu X; Huang CY; Tsai FJ; Tsai CH; Watabe K; Lin HK
Mol Cell; 2016 Nov; 64(4):803-814. PubMed ID: 27818144
[TBL] [Abstract][Full Text] [Related]
14. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.
Khan DH; Gonzalez C; Cooper C; Sun JM; Chen HY; Healy S; Xu W; Smith KT; Workman JL; Leygue E; Davie JR
Nucleic Acids Res; 2014 Feb; 42(3):1656-70. PubMed ID: 24234443
[TBL] [Abstract][Full Text] [Related]
15. The role of post-translational modifications in the regulation of MCL1.
Li S; Guo W; Wu H
Cell Signal; 2021 May; 81():109933. PubMed ID: 33508399
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation of MCL1 protein enhances its stability by regulating the ubiquitin-proteasome pathway.
Li S; Wang J; Hu G; Aman S; Li B; Li Y; Xia K; Yang Y; Ahmad B; Wang M; Wu H
Cell Signal; 2020 Sep; 73():109686. PubMed ID: 32504673
[TBL] [Abstract][Full Text] [Related]
17. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
[TBL] [Abstract][Full Text] [Related]
18. Histone acetyltransferase p300 is induced by p38MAPK after photodynamic therapy: the therapeutic response is increased by the p300HAT inhibitor anacardic acid.
Tsai YJ; Tsai T; Peng PC; Li PT; Chen CT
Free Radic Biol Med; 2015 Sep; 86():118-32. PubMed ID: 26001729
[TBL] [Abstract][Full Text] [Related]
19. N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression.
Xu H; Jiang B; Meng L; Ren T; Zeng Y; Wu J; Qu L; Shou C
Carcinogenesis; 2012 Jun; 33(6):1193-202. PubMed ID: 22496479
[TBL] [Abstract][Full Text] [Related]
20. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
Lee YC; Chen YJ; Huang CH; Chang LS
Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
